Camber Pharma Launches Generic Strattera®
Piscataway, NJ, May 24, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Atomoxetine Capsules, which is the generic version of Strattera®
Atomoxetine Capsules are used to treat attention-deficit hyperactivity disorder (ADHD).
Atomoxetine Capsules are available from Camber in 10, 18, 25, 40, 60, 80 and 100 mg- 30 count bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class






